Several studies have identified CA125/MUC16 as a tumor microenvironment factor, often elevated (above the normal 35 U/ml level) in the serum of up to 40% of FL and other NHL patients [5]. The gene discussed is MUC16; the disease is non-Hodgkin lymphoma.